当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析 - 现金流量表

华森制药

(002907)

  

流通市值:49.31亿  总市值:68.65亿
流通股本:3.00亿   总股本:4.18亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金410,213,008.49184,687,189.98759,844,821.05556,410,791.95
  收到的税费返还1,438,103.711,438,103.713,723,287.023,723,287.02
  收到其他与经营活动有关的现金12,246,976.575,549,959.8236,405,297.5332,016,877.6
  经营活动现金流入小计423,898,088.77191,675,253.51799,973,405.6592,150,956.57
  购买商品、接受劳务支付的现金130,299,225.3739,134,249.76183,945,279.88140,454,306.56
  支付给职工以及为职工支付的现金81,835,620.8348,068,885.95147,061,248.09111,255,653.62
  支付的各项税费57,981,836.7122,689,056.9984,545,592.4958,340,739.33
  支付其他与经营活动有关的现金126,255,067.2259,922,117.76222,654,476.12175,219,680.01
  经营活动现金流出小计396,371,750.13169,814,310.46638,206,596.58485,270,379.52
  经营活动产生的现金流量净额27,526,338.6421,860,943.05161,766,809.02106,880,577.05
二、投资活动产生的现金流量:
  收回投资收到的现金230,000,000120,000,000344,653,775.24213,175,417.55
  取得投资收益收到的现金1,781,185.51,203,411.523,874,331.161,515,313.75
  处置固定资产、无形资产和其他长期资产收回的现金净额--3,5003,500
  投资活动现金流入小计231,781,185.5121,203,411.52348,531,606.4214,694,231.3
  购建固定资产、无形资产和其他长期资产支付的现金4,679,728.182,374,756.7316,151,133.1512,410,595.64
  投资支付的现金400,000,000300,000,000439,589,930.55439,589,930.55
  取得子公司及其他营业单位支付的现金-447,333.24---
  投资活动现金流出小计404,232,394.94302,374,756.73455,741,063.7452,000,526.19
  投资活动产生的现金流量净额-172,451,209.44-181,171,345.21-107,209,457.3-237,306,294.89
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金20,879,815.7-35,495,684.7235,495,684.72
  支付其他与筹资活动有关的现金6,063,274.1728,800138,360138,360
  筹资活动现金流出小计26,943,089.8728,80035,634,044.7235,634,044.72
  筹资活动产生的现金流量净额-26,943,089.87-28,800-35,634,044.72-35,634,044.72
四、汇率变动对现金及现金等价物的影响-131,580.48-136,374.9563,769.26-45,680.88
五、现金及现金等价物净增加额-171,999,541.15-159,475,577.1118,987,076.26-166,105,443.44
  加:期初现金及现金等价物余额456,551,895.4456,552,929.38437,564,819.14437,564,819.14
  期末现金及现金等价物余额284,552,354.25297,077,352.27456,551,895.4271,459,375.7
补充资料:
  净利润52,286,443.02-76,730,225.12-
  资产减值准备240,732.9-3,495,457.14-
  固定资产和投资性房地产折旧33,639,802.44-68,715,305.37-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,639,802.44-68,715,305.37-
  无形资产摊销9,911,181.76-18,126,985.54-
  长期待摊费用摊销1,432,777.79-2,451,352.44-
  固定资产报废损失234,733.67-32,253.89-
  公允价值变动损失-755,500.26--7,518,348.83-
  财务费用51,406.84--3,309,487.81-
  投资损失-15,570,992.36-6,140,731.36-
  递延所得税14,316,058.55--766,316.82-
  其中:递延所得税资产减少2,079,830.95--1,594,090.42-
    递延所得税负债增加12,236,227.6-827,773.6-
  存货的减少19,379,383.69-10,588,748.99-
  经营性应收项目的减少-76,328,150.38--30,297,824.64-
  经营性应付项目的增加-11,382,777.22-17,279,047.44-
  现金的期末余额284,552,354.25-456,551,895.4-
  减:现金的期初余额456,551,895.4-437,564,819.14-
  现金及现金等价物的净增加额-171,999,541.15-18,987,076.26-
公告日期2025-08-222025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑